Varun Monga

2.5k total citations
81 papers, 1.1k citations indexed

About

Varun Monga is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Varun Monga has authored 81 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 31 papers in Pulmonary and Respiratory Medicine and 18 papers in Molecular Biology. Recurrent topics in Varun Monga's work include Sarcoma Diagnosis and Treatment (26 papers), Glioma Diagnosis and Treatment (16 papers) and Vascular Tumors and Angiosarcomas (10 papers). Varun Monga is often cited by papers focused on Sarcoma Diagnosis and Treatment (26 papers), Glioma Diagnosis and Treatment (16 papers) and Vascular Tumors and Angiosarcomas (10 papers). Varun Monga collaborates with scholars based in United States, Australia and Canada. Varun Monga's co-authors include Mohammed Milhem, Yousef Zakharia, Bryan G. Allen, Douglas R. Spitz, Munir R. Tanas, Sarah L. Mott, John M. Buatti, Sarv Priya, Corinne E. Griguer and Prabhat C. Goswami and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Varun Monga

78 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Varun Monga United States 19 372 355 283 262 171 81 1.1k
Yasuo Ejima Japan 20 379 1.0× 394 1.1× 332 1.2× 106 0.4× 178 1.0× 49 1.3k
Fable Zustovich Italy 18 317 0.9× 528 1.5× 298 1.1× 207 0.8× 92 0.5× 87 949
Monika Hackl Austria 18 1.0k 2.7× 636 1.8× 325 1.1× 325 1.2× 140 0.8× 40 1.7k
Conleth G. Murphy Ireland 19 1.0k 2.7× 430 1.2× 322 1.1× 146 0.6× 188 1.1× 55 1.5k
Hao‐Wen Sim Australia 17 326 0.9× 327 0.9× 364 1.3× 162 0.6× 48 0.3× 73 931
Véronique D’Hondt France 21 781 2.1× 335 0.9× 298 1.1× 99 0.4× 110 0.6× 83 1.3k
Tatsunori Shimoi Japan 16 775 2.1× 422 1.2× 229 0.8× 66 0.3× 243 1.4× 105 1.2k
Miguel Gil‐Gil Spain 23 814 2.2× 619 1.7× 322 1.1× 600 2.3× 216 1.3× 101 1.7k
Lisa Doherty United States 18 247 0.7× 323 0.9× 445 1.6× 814 3.1× 96 0.6× 40 1.4k
Ciara C. O’Sullivan United States 18 590 1.6× 262 0.7× 293 1.0× 114 0.4× 137 0.8× 72 1.0k

Countries citing papers authored by Varun Monga

Since Specialization
Citations

This map shows the geographic impact of Varun Monga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Varun Monga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Varun Monga more than expected).

Fields of papers citing papers by Varun Monga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Varun Monga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Varun Monga. The network helps show where Varun Monga may publish in the future.

Co-authorship network of co-authors of Varun Monga

This figure shows the co-authorship network connecting the top 25 collaborators of Varun Monga. A scholar is included among the top collaborators of Varun Monga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Varun Monga. Varun Monga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, I‐Chow, Kevin Lu, Katherine C. Fuh, et al.. (2025). Complete response of somatic POLE-ultramutated recurrent undifferentiated uterine sarcoma to pembrolizumab and concurrent radiotherapy. Gynecologic Oncology Reports. 60. 101814–101814.
2.
Monga, Varun, et al.. (2025). The Decline and Fall of the Current Chemotherapy Paradigm in Soft Tissue Sarcoma. Cancers. 17(7). 1203–1203. 1 indexed citations
3.
Ferrarotto, Renata, Paul Swiecicki, Dan P. Zandberg, et al.. (2023). PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study. Oral Oncology. 149. 106634–106634. 19 indexed citations
4.
DuVall, Adam, Brandon Hayes‐Lattin, Pinki Prasad, et al.. (2023). Gaps in Adolescent and Young Adult Cancer Education in Oncology Fellowship Training. Journal of Adolescent and Young Adult Oncology. 13(1). 97–104. 6 indexed citations
5.
Dodd, Rebecca D., et al.. (2022). Epigenetic modulation in sensitizing metastatic sarcomas to therapies and overcoming resistance. Cancer Drug Resistance. 5(1). 25–35. 2 indexed citations
6.
Gutierrez, Wade R., Vickie Knepper-Adrian, Dawn E. Quelle, et al.. (2022). Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanism. JCI Insight. 7(22). 7 indexed citations
7.
Dubin, Justin M., William W. Terry, Varun Monga, et al.. (2022). Sexual Dysfunction Among Adolescent and Young Adult Men Diagnosed with Cancer. Journal of Adolescent and Young Adult Oncology. 12(1). 93–100. 2 indexed citations
8.
Priya, Sarv, Caitlin Ward, Thomas Locke, et al.. (2021). Glioblastoma and primary central nervous system lymphoma: differentiation using MRI derived first-order texture analysis – a machine learning study. The Neuroradiology Journal. 34(4). 320–328. 14 indexed citations
9.
10.
Priya, Sarv, Yanan Liu, Caitlin Ward, et al.. (2021). Radiomic Based Machine Learning Performance for a Three Class Problem in Neuro-Oncology: Time to Test the Waters?. Cancers. 13(11). 2568–2568. 19 indexed citations
11.
Tanas, Munir R., Fatima Toor, Benjamin J. Miller, et al.. (2021). Photodynamic Therapy Using Hippo Pathway Inhibitor Verteporfin: A Potential Dual Mechanistic Approach in Treatment of Soft Tissue Sarcomas. Cancers. 13(4). 675–675. 5 indexed citations
13.
Agulnik, Mark, Brian Schulte, Steven I. Robinson, et al.. (2021). An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma. European Journal of Cancer. 154. 201–208. 17 indexed citations
15.
Woodroffe, Royce W., Neetu Soni, Sarah L. Mott, et al.. (2020). Survival after reoperation for recurrent glioblastoma. Journal of Clinical Neuroscience. 73. 118–124. 18 indexed citations
16.
Ryan, Ginny L., et al.. (2019). Factors Impacting Fertility Preservation in Adolescents and Young Adults with Cancer: A Retrospective Study. Journal of Adolescent and Young Adult Oncology. 9(2). 208–221. 17 indexed citations
17.
Monga, Varun, et al.. (2018). Discrepancy between treatment goals documentation by oncologists and their understanding among cancer patients under active treatment with chemotherapy. European Journal of Cancer Care. 28(2). e12973–e12973. 12 indexed citations
18.
Mapuskar, Kranti A., Kyle H. Flippo, Joshua D. Schoenfeld, et al.. (2017). Mitochondrial Superoxide Increases Age-Associated Susceptibility of Human Dermal Fibroblasts to Radiation and Chemotherapy. Cancer Research. 77(18). 5054–5067. 31 indexed citations
19.
Monga, Varun, Seth Maliske, & Usha Perepu. (2017). Fatal pulmonary embolism following splenectomy in a patient with Evan’s syndrome: case report and review of the literature. Thrombosis Journal. 15(1). 18–18. 2 indexed citations
20.
Monga, Varun & Margarida Silverman. (2015). Pulmonary Extramedullary Hematopoiesis Involving the Pulmonary Artery. Hematology Reports. 7(1). 5714–5714. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026